Danaher Corporation
Danaher Corporation is a healthcare-focused conglomerate with significant doctor payment programs ($4.6M in 2024) and active trading by three members of Congress.
BusinessWhat DHR does
Danaher is a global science and technology innovator operating in the healthcare and life sciences sectors. Its business model involves designing, manufacturing, and marketing professional, medical, industrial, and commercial products and services. Key revenue lines include diagnostics, life sciences, and environmental & applied solutions, with major subsidiaries like Beckman Coulter and Cepheid.
12 months past · 3 months futureDHR activity timeline
Executive Branch ConflictsDHR held by Trump-administration officials
Lifetime Government AwardsDHR federal contracts
DHR doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding DHR
Politicians Trading DHRMembers of Congress with recent DHR positions
Congressional TradesWho in Congress is trading DHR
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting DHRLive legislation impacting this stock
Political ProfileWhere DHR sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) from 8 healthcare bills and doctor payment exposure ($4.6M in 2024). EVIDENTIARY: Active congressional trading (3 members, 16 trades) and two executive branch holdings, but zero lobbying spend, zero corporate insider buys, and no federal contract history. Net: Evidentiary activity is offset by lack of structural political investment.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of doctor payment programs under the Sunshine Act.CMS (Centers for Medicare & Medicaid Services)"`get_political_influence.doctor_payments` shows $4.6M in 2024 and $6.2M in 2023 payments from Beckman Coulter."
Regulatory opportunities
-
Potential for favorable reimbursement policies for diagnostic equipment.CMS"Eight recent healthcare bills with positive estimated revenue impact per `bill_impacts` array."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for DHR — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades DHR
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord